Hysteroscopic removal of intrauterine devices (IUDs) during the first trimester is a viable option for patients who wish to continue their pregnancy, according to a presentation at the AAGL 2019 Global Conference.
Hysteroscopic removal of intrauterine devices (IUDs) during the first trimester is a viable option for patients who wish to continue their pregnancy, according to DI Nassie, MD, who presented on this topic at the 2019 American Association of Gynecologic Laparoscopists (AAGL) Global Congress on minimally invasive gynecologic surgery (MIGS) in Vancouver, British Columbia.
Background
Dr. Nassie, of the Helen Schneider Hospital for Women, Rabin Medical Center, Petach Tiqva, Israel, and the Sackler School of Medicine, Tel-Aviv University, noted that while use IUDs has increased in recent years over oral contraceptives, there continues to be inherent failure rates with IUDs, which result in women becoming pregnant with a device in place.
The Food and Drug Administration (FDA) and the World Health Organization (WHO) both recommend IUD removal in the face of pregnancy, specifically due to the possibilities of miscarriage, placental abnormalities, chorioamnionitis, and preterm delivery. However, when the strings are not visible, the consensus is less clear. The choices are to leave the device in situ, attempt to blindly remove it, remove it with sonographic guidance, or attempt removal via hysteroscopy.
Methods
In Dr. Nassie’s study, seven women in the first trimester underwent IUD removal without anesthesia or cervical dilation utilizing a 3.5-mm Gynecare Versascope. Prior to the procedure, they were all were given prophylactic antibiotics and received vaginal prep with antiseptic solution. The uterus was distended with 0.9% saline until a clear view was achieved and then the infusion was stopped or slowed to decrease risk of hydro-dissection of the gestational sac. When the strings of the IUD were located, they were grasped using semirigid SF grasping forceps, and the device was gently removed. After removal, the fetal pulse was verified by ultrasound. All the women were discharged on the operative day.
Findings
Dr. Nassie reported that all patients went on to have spontaneous vaginal deliveries at term. All infants were reported to be of appropriate weight for their gestational ages. No complications of pregnancy or placentation were reported.
Conclusion
“Hysteroscopic removal of an IUD in the first trimester is a safe option when the strings are not visible. It is not associated, according to our data, with major adverse pregnancy outcomes,” said Dr. Nassie. “This procedure should be offered to gravid women in the first trimester who desire to preserve pregnancy.”
Phase 2b safety data for Sildenafil Cream against FSAD reported
August 26th 2024In a recent study published in The Journal of Sexual Medicine, Sildenafil Cream, 3.6% was indicated as safe and well-tolerated for use against female sexual arousal disorder in healthy premenopausal women.
Read More
Study: Pelvic floor dilator reduces pelvic floor muscle injury during vaginal delivery
August 6th 2024A new pilot study published in the International Urogynecology Journal found that Materna Medical’s Prep Device, a pelvic floor dilator, reduced full levator ani muscle avulsion during vaginal delivery in first-time mothers.
Read More
Similar success rates for synthetic and nonsynthetic slings in SUI treatment
July 31st 2024A study found that both synthetic and nonsynthetic slings show similar success rates for treating stress urinary incontinence in women, with synthetic slings demonstrating improved operative outcomes and reduced complications.
Read More
First hysterectomy using miniaturized MIRA Surgical System performed
July 30th 2024Virtual Incision Corporation has announced the successful performance of the first benign hysterectomy using their miniaturized robotic-assisted surgery device, MIRA, in a clinical trial assessing its safety and efficacy.
Read More